Tumoral calcinosis: Clinical and biochemical aspects of a patient treated with vinpocetine

European Journal of Internal Medicine

Volumn 17, Issue 6, 2006, Pages 436-438

  Seyahi, Aksel ^a   Atalar, Ata Can ^b   Ergin, Hulya Karadayi ^c  

^a AMERICAN HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c SB Göztepe Egitim ve Arastirma Hastanesi ^*  (Turkey)

Author keywords

Hemodialysis; Metastatic calcification; Renal failure; Tumoral calcinosis; Vinpocetine

Indexed keywords

CALCIUM PHOSPHATE; PARATHYROID HORMONE; PARICALCITOL; SEVELAMER; VINCA ALKALOID; VINPOCETINE;

ADULT; ARTICLE; BIOCHEMISTRY; CALCIFICATION; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE COURSE; DRUG EFFICACY; FEMALE; HIP; HUMAN; HYPERPARATHYROIDISM; TREATMENT OUTCOME; TUMOR CALCINOSIS;

EID: 33750216864     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.02.015     Document Type: Article

References (6)

1. Drüeke T.B. A clinical approach to the uraemic patient with extraskeletal calcifications. Nephrol Dial Transplant 11 Suppl. 3 (1996) 37-42
2. Seyahi N., Apaydin S., Sariyar M., Serdengecti K., and Erek E. Intracranial calcification and tumoral calcinosis during Vitamin D therapy. Nephrology 9 2 (2004 (Apr)) 89-93
3. Mockel G., Buttgereit F., Labs K., and Perka C. Tumoral calcinosis revisited: pathophysiology and treatment. Rheumatol Int 25 1 (2005 (Jan)) 55-59
4. Ueyoshi A., and Ota K. Clinical appraisal of vinpocetine for the removal of intractable tumoral calcinosis in haemodialysis patients with renal failure. J Int Med Res 20 5 (1992 (Sep)) 435-443
5. Balestreri R., Fontana L., and Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 35 5 (1987) 425-430
6. Feigin V.L., Doronin B.M., Popova T.F., et al. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur J Neurol 8 1 (2001) 81